Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

Bullboard Posts

Comment by BigPoppaStockon Aug 12, 2019 11:35pm

196 Views

Post# 30020588

RE:RE:RE:RE:RE:RE:RE:75 kg/week output

Agree with your analysis. The inventory is huge. Relationships should allow Medipharm to continue to have access to biomass. I do believe the bottleneck is in the extraction space at the moment. With all of the production coming onboard, the capacity can't keep up with demand and the demand will only continue to increase. There's enough business out there for multiple businesses to play ball. Medipharm just happens to be the best of them all. I believe the financials exceeded all analyst expectations. I anticipate targets will be rerated higher.

Bullboard Posts

This junior mining stock offers billions in market exposure